Introduction to the seminar series: Optimal management during ADT to mitigate complications

In this special edition of Urologic Oncology, we are addressing the effects of androgen deprivation therapy (ADT) for men with prostate cancer. The contributors to this edition were invited based their areas of expertise and willingness to present updated and practical information for providers involved in the care of prostate cancer patients. Drs. Melloni and Roe present current data on androgen deprivation therapy and cardiovascular disease. Management of bone and metabolic effects is reviewed by Drs.
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Tags: Seminars article Source Type: research